Drug-induced lung injury / Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba, editors.
Hanaoka, Masayuki, editor.; Nakamura, Hiroyuki, editor.; Aoshiba, Kazutetsu, editor.
2018
RD539
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Drug-induced lung injury / Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba, editors.
ISBN 9789811044663 (electronic book)
981104466X (electronic book)
9789811044656
DOI https://doi.org/10.1007/978-981-10-4466-3
Published Singapore : Springer, [2018]
Language English
Description 1 online resource.
Other Standard Identifiers 10.1007/978-981-10-4466-3 doi
Call Number RD539
Dewey Decimal Classification 616.2/4
Bibliography, etc. Note Includes bibliographical references.
Access Note Access limited to authorized users.
Digital File Characteristics text file PDF
Source of Description Online resource; title from PDF title page (viewed October 30, 2017).
Added Author Hanaoka, Masayuki, editor.
Nakamura, Hiroyuki, editor.
Aoshiba, Kazutetsu, editor.
Series Respiratory disease series.
Available in Other Form Print version: 9789811044656
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Part I Definition, Pathogenesis, and Epidemiology
1. Definition, Pathogenesis and Epidemiology: What is DLI
2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI
3. Clinical Characteristics of DLI: What are the clinical features of DLI
Part II Diagnosis
4. Diagnostic Approach for DLI: How is DLI diagnosed
5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI
6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted
7. Pathology of DLI: What is the pathological significance of DLI
8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI
Part II Treatment
9. Therapeutic Strategies for DLI: How should DLI be treated
Part IV Drugs Causing DLI
10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs
11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs
12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs
13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines
14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs.

Browse Subjects

Show more subjects...

Statistics

from
to
Export